Puma Biotechnology | Der Umsatz



Sales Veränderung Datum
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Daiichi Sankyo JPY 518.69B 33.85B 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.05B 128.7M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Moderna USD 108M 858M 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Takeda JPY 1.05T 90B 2025-03
TG Therapeutics USD 119.7M 11.51M 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Puma Biotechnology Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.